References

1. GINA. Global Strategy for Asthma Management and Prevention. Secondary Global Strategy for Asthma Management and Prevention 2014
2. Vijverberg SJ, Hilvering B, Raaijmakers JA, Lammers JW, Maitland-van der Zee AH, et al. (2013) Clinical utility of asthma biomarkers: from bench to bedside. Biologics 7: 199-210 [CrossRef] [Google Scholar] [PubMed]
3. Murugan A, Prys-Picard C, Calhoun WJ (2009) Biomarkers in asthma. Curr Opin Pulm Med 15: 12-18 [CrossRef]
4. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, et al. (2010) National Heart, Lung, and Blood Institute's Severe Asthma Research Program. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J RespirCrit Care Med 181: 315-323 [CrossRef] [Google Scholar] [PubMed]
5. Erzurum SC, Gaston BM (2012) Biomarkers in asthma: a real hope to better manage asthma. Clin Chest Med 33: 459-471 [CrossRef] [Google Scholar] [PubMed]
6. Baraldi E, Carraro S (2006) Exhaled NO and breath condensate. PaediatrRespir Rev 1: S20-2 [CrossRef] [PubMed]
7. American Thoracic Society, European Respiratory Society (2005) ATS/ ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J RespirCrit Care Med 171: 912-930 [CrossRef] [Google Scholar] [PubMed]
8. Raymer JH, Thomas KW, Cooper SD, Whitaker DA, Pellizzari ED, et al. (1990) A device for sampling of human alveolar breath for the measurement of expired volatile organic compounds. J Anal Toxicol 14: 337-344 [CrossRef] [Google Scholar] [PubMed]
9. Deykin A, Massaro AF, Drazen JM, Israel E (2002) Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rate. Am J RespirCrit Care Med 165: 1597-1601 [CrossRef] [Google Scholar] [PubMed]
10. Robroeks CM, Van Berkel JJ, Dallinga JW, Jöbsis Q, Zimmermann LJ, et al. (2010) Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res 68: 75-80 [CrossRef] [Google Scholar] [PubMed]
11. Fens N, Zwinderman AH, van der Schee MP, de Nijs SB, Dijkers E, et al. (2009) Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J RespirCrit Care Med 180: 1076–1082 [CrossRef] [Google Scholar] [PubMed]
12. Robroeks CM, van Berkel JJ, Jöbsis Q, van Schooten FJ, Dallinga JW, et al. (2013) Exhaled volatile organic compounds predict exacerbations of childhood asthma in a 1-year prospective study. Eur Respir J 42: 98-106 [CrossRef] [Google Scholar] [PubMed]
13. Turner S (2015) Exhaled nitric oxide and the management of childhood asthma-yet another promising biomarker "has been" or a misunderstood gem. Paediatr Respir Rev 16: 88-96 [CrossRef] [Google Scholar] [PubMed]
14. Kharitonov SA, Yates DH, Barnes PJ (1996) Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J RespirCrit Care Med 153: 454-457 [CrossRef] [Google Scholar] [PubMed]
15. Pijnenburg MW, De Jongste JC (2008) Exhaled nitric oxide in childhood asthma: a review. ClinExp Allergy 38: 246-259 [CrossRef] [Google Scholar] [PubMed]
16. Baraldi E, de Jongste JC; European Respiratory Society/American Thoracic Society (ERS/ATS) Task Force (2002) Measurement of exhaled nitric oxide in children, 2001. Eur Respir J 20: 223-237 [CrossRef] [Google Scholar] [PubMed]
17. Moschino L, Zanconato S, Bozzetto S, Baraldi E, Carraro S, et al. (2015) Childhood asthma biomarkers: present knowledge and future steps. Paediatr Respir Rev 16: 205-212 [CrossRef] [Google Scholar] [PubMed]
18. Covar RA, Szefler SJ, Martin RJ, Sundstrom DA, Silkoff PE, et al. (2003) Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 142: 469-475 [CrossRef] [Google Scholar] [PubMed]
19. Komakula S, Khatri S, Mermis J, Savill S, Haque S, et al. (2007) Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics. Respir Res 8: 32 [CrossRef] [Google Scholar] [PubMed]
20. Ludviksdottir D, Diamant Z, Alving K, Bjermer L, Malinovschi A, et al. (2012) Clinical aspects of using exhaled NO in asthma diagnosis and management. Clin Respir J 6: 193-207 [CrossRef] [Google Scholar] [PubMed]
21. Mahr TA, Malka J, Spahn JD (2013) Inflammometry in pediatric asthma: a review of fractional exhaled nitric oxide in clinical practice. Asthma Proc 34: 210-219 [CrossRef] [Google Scholar] [PubMed]
22. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, et al. (2011) An official ATS clinical practice guideline: interpretation of exhaled nitric oxide level (FENO) for clinical applications. Am J Respir Crit Care Med 184: 602- 615 [CrossRef] [Google Scholar] [PubMed]
23. Taylor DR (2012) Advances in the clinical applications of exhaled nitric oxide measurements. J Breath Res 6: 047102 [CrossRef] [Google Scholar] [PubMed]
24. van Rensen EL, Straathof KC, Veselic-Charvat MA, Zwinderman AH, Bel EH, et al. (1999) Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma. Thorax 54: 403-408 [CrossRef] [Google Scholar] [PubMed]
25. Sorkness CA, Wildfire JJ, Calatroni A, Mitchell HE, Busse WW, et al. (2013) Reassessment of omalizumab-dosing strategies and pharmacodynamics in inner-city children and adolescents. J Allergy ClinImmunol Pract 1: 163- 171 [CrossRef] [Google Scholar] [PubMed]
26. Wenzel S, Castro M, Corren J, Maspero J, Wang L, et al. (2016) Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lance 388: 31-44 [CrossRef] [Google Scholar] [PubMed]
27. Petsky HL, Cates CJ, Lasserson TJ, Li AM, Turner C, et al. (2012) A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 6: 199-208 [CrossRef] [Google Scholar] [PubMed]
28. Jartti T, Wendelin-Saarenhovi M, Heinonen I, Hartiala J, Vanto T, et al. (2012) Childhood asthma management guided by repeated FeNO measurements: a meta-analysis. Paediatr Respir Rev 13: 178-183 [CrossRef] [Google Scholar] [PubMed]
29. Bjermer L, Alving K, Diamant Z, Magnussen H, Pavord I, et al. (2014) Current evidence and future research needs for FeNO measurement in respiratory diseases. Respir Med 108: 830-841 [CrossRef] [Google Scholar] [PubMed]
30. Buszewski B, Kesy M, Ligor T, Amann A (2007) Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr 21: 553-566 [CrossRef] [Google Scholar] [PubMed]
31. van Mastrigt E, de Jongste JC, Pijnenburg MW (2015) The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys? ClinExp Allergy 45: 1170-1188 [CrossRef] [Google Scholar] [PubMed]
32. Barker M, Hengst M, Schmid J, Buers HJ, Mittermaier B, et al. (2006) Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. EurRespir J 27: 929-936 [CrossRef] [Google Scholar] [PubMed]
33. Dallinga JW, Robroeks CM, van Berkel JJ, Moonen EJ, Godschalk RW, et al. (2010) Volatile organic compounds in exhaled breath as a diagnostic tool for asthma in children. ClinExp Allergy 40: 68-76 [CrossRef] [Google Scholar] [PubMed]
34. Caldeira M, Barros AS, Bilelo MJ, Parada A, Câmara JS, et al. (2011) Profiling allergic asthma volatile metabolic patterns using a headspacesolid phase micro extraction/gas chromatography based methodology. J Chromatogr A 1218: 3771-3780 [CrossRef] [Google Scholar] [PubMed]
35. Dent AG, Sutedja TG, Zimmerman PV (2013) Exhaled breath analysis for lung cancer. J Thorac Dis 5:S540-550 [CrossRef] [Google Scholar] [PubMed]
36. Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, et al. (2005) ATS/ERS Task Force on Exhaled Breath Condensate. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26: 523-548 [CrossRef] [Google Scholar] [PubMed]
37. Paget-Brown AO, Ngamtrakulpanit L, Smith A, Bunyan D, Hom S, et al. (2006) Normative data for pH of exhaled breath condensate. Chest 129: 426-430 [CrossRef] [Google Scholar] [PubMed]
38. Carraro S, Folesani G, Corradi M, Zanconato S, Gaston B, et al. (2005) Acid-base equilibrium in exhaled breath condensate of allergic asthmatic children. Allergy 60: 476-481 [CrossRef] [Google Scholar] [PubMed]
39. Brunetti L, Francavilla R, Tesse R, Fiermonte P, Fiore FP, et al. (2008) Exhaled breath condensate cytokines and pH in pediatric asthma and atopic dermatitis. Allergy Asthma Proc 29: 461-467 [CrossRef] [Google Scholar] [PubMed]
40. Rosias PP, Dompeling E, Dentener MA, Pennings HJ, Hendriks HJ, et al. (2004) Childhood asthma: exhaled markers of airway inflammation, asthma control score, and lung function tests. Pediatr Pulmonol 38: 107-114 [CrossRef] [Google Scholar] [PubMed]
41. Ratnawati, Morton J, Henry RL, Thomas PS (2006) Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol 41: 929-936 [CrossRef] [Google Scholar] [PubMed]
42. Jöbsis Q, Raatgeep HC, Hermans PW, de Jongste JC (1997) Hydrogen peroxide in exhaled air is increased in stable asthmatic children. Eur Respir J 10: 519-521 [Google Scholar] [PubMed]
43. Caffarelli C, Calcinai E, Rinaldi L, PovesiDascola C, Terracciano L, et al. (2012) Hydrogen peroxide in exhaled breath condensate in asthmatic children during acute exacerbation and after treatment. Respiration 84: 291-298 [CrossRef] [Google Scholar] [PubMed]
44. Trischler J, Merkel N, Könitzer S, Müller CM, Unverzagt S, et al. (2012) Fractionated breath condensate sampling: H(2)O(2) concentrations of the alveolar fraction may be related to asthma control in children. Respir Res 13: 14 [CrossRef] [Google Scholar] [PubMed]
45. Robroeks CM, van Vliet D, Jöbsis Q, Braekers R, Rijkers GT, et al. (2012) Prediction of asthma exacerbations in children: results of a one-year prospective study. ClinExp Allergy 42: 792-798 [CrossRef] [Google Scholar] [PubMed]
46. Carraro S, Giordano G, Piacentini G, Kantar A, Moser S, et al. (2013) Asymmetric dimethylarginine in exhaled breath condensate and serum of children with asthma. Chest 144: 405-410 [CrossRef] [Google Scholar] [PubMed]
47. Corradi M, Folesani G, Andreoli R, Manini P, Bodini A, et al. (2003) Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med. 167: 395-399 [CrossRef] [Google Scholar] [PubMed]
48. Romieu I, Barraza-Villarreal A, Escamilla-Nuñez C, Almstrand AC, Diaz- Sanchez D, et al. (2008) Exhaled breath malondialdehyde as a marker of effect of exposure to air pollution in children with asthma. J Allergy ClinImmunol 121: 903-909 [CrossRef] [Google Scholar] [PubMed]
49. Baraldi E, Carraro S, Alinovi R, Pesci A, Ghiro L, et al. (2003) Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations. Thorax 58: 505-509 [CrossRef] [Google Scholar] [PubMed]
50. Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ, et al. (2005) Exhaled 8-isoprostane in childhood asthma. Respir Res 6: 79 [CrossRef] [Google Scholar] [PubMed]
51. Loukides S, Kontogianni K, Hillas G, Horvath I (2011) Exhaled breath condensate in asthma: from bench to bedside. Curr Med Chem 18: 1432- 1443 [CrossRef] [Google Scholar] [PubMed]
52. Thomas PS, Lowe AJ, Samarasinghe P, Lodge CJ, Huang Y et al. (2013) Exhaled breath condensate in pediatric asthma: promising new advance or pouring cold water on a lot of hot air? a systematic review. Pediatr Pulmonol 48: 419-442 [CrossRef] [Google Scholar] [PubMed]
53. Csoma Z, Kharitonov SA, Balint B, Bush A, Wilson NM, et al. (2002) Increased leukotrienes in exhaled breath condensate in childhood asthma. Am J RespirCrit Care Med 166: 1345-1349 [CrossRef] [Google Scholar] [PubMed]
54. Debley JS, Hallstrand TS, Monge T, Ohanian A, Redding GJ, et al. (2007) Methods to improve measurement of cysteinyl leukotrienes in exhaled breath condensate from subjects with asthma and healthy controls. J Allergy ClinImmunol 120: 1216-1217 [CrossRef] [Google Scholar] [PubMed]
55. Steiss JO, Rudloff S, Landmann E, Rückes-Nilges C, Zimmer KP, et al. (2008) Effect of inhaled corticosteroid treatment on exhaled breath condensate leukotriene E(4) in children with mild asthma. Allergy Asthma Proc 29: 371-375 [CrossRef] [Google Scholar] [PubMed]
56. Montuschi P, Mondino C, Koch P, Barnes PJ, Ciabattoni G, et al. (2006) Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. J Allergy Clin Immunol 118: 347-353 [CrossRef] [Google Scholar] [PubMed]
57. Karakoc GB, Yukselen A, Yilmaz M, Altintas DU, Kendirli SG, et al. (2012) Exhaled breath condensate MMP-9 level and its relationship wıth asthma severity and interleukin-4/10 levels in children. Ann Allergy Asthma Immunol 108: 300-304 [CrossRef] [Google Scholar] [PubMed]
58. Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ, et al. (2002) Increased interleukin-4 and decreased interferon-gamma in exhaled breath condensate of children with asthma. Am J RespirCrit Care Med 165: 1290- 1293 [CrossRef] [Google Scholar] [PubMed]